•   
  •   

World S.Africa to pay 2.5 times more than EU for virus vaccine

21:43  21 january  2021
21:43  21 january  2021 Source:   msn.com

It’s essential to understand why some health care workers are putting off vaccination

  It’s essential to understand why some health care workers are putting off vaccination Early data on why health care workers are delaying the Covid-19 vaccine could help us end the pandemic sooner.It’s a troubling development, especially since health care workers are at higher risk of contracting the virus and are essential in our efforts to treat record numbers of Covid-19 patients. Some public health experts also hoped this group would be relatively easy to vaccinate — and could help pave the way for broader vaccine acceptance.

South Africa will pay .25 per dose for COVID-19 vaccines from the Serum Institute of India (SII) - well above what others, including developed nations, are paying for the same shots, local newspaper Business Day reported on Thursday. The Business Day report cited health department Deputy

(Bloomberg) -- South Africa ’ s government, lauded for its swift lockdown in March to curb the spread of the Their explanations, and those of other officials, range from not having the money to pay for shots upfront Much of the criticism is directed at the Ministerial Advisory Committee on Vaccines and its

South Africa will buy doses of Oxford-AstraZeneca's Covid-19 vaccine at a price 2.5 times higher than most European countries, the health ministry said Thursday.

a man standing in front of a table: South Africa has recorded nearly 39,000 Covid deaths and is battling a second wave of infections © Guillem Sartorio South Africa has recorded nearly 39,000 Covid deaths and is battling a second wave of infections

The continent's worst virus-hit country has ordered at least 1.5 million shots of the vaccine from the Serum Institute of India, expected in January and February.

A senior health official on Thursday told AFP those doses would cost $5.25 (4.32 euros) each -- nearly 2.5 times the amount paid by most European countries.

"The National Department of Health confirms that the price $5.25 is what was quoted to us," deputy director-general of health Anban Pillay said via text message, without explaining the price difference.

Scientists clarify position, say 'AstraZeneca vaccine an important advance' in Australia's fight against COVID-19

  Scientists clarify position, say 'AstraZeneca vaccine an important advance' in Australia's fight against COVID-19 A group of scientists has clarified its position on the AstraZeneca vaccine, saying it did not call for the rollout to be paused and the drug is an "important advance" in Australia's fight against COVID-19.Earlier today, some media reports said the Australian and New Zealand Immunology Society (ASI) supported halting the widespread use of the AstraZeneca vaccine in favour of the Pfizer drug.

South African variant may resist current antibody treatments. The variant of the new coronavirus identified in South Africa can resist, or "escape The COVID-19 vaccine from Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) is likely to protect against the more infectious variant of the virus

The African Union established the African vaccine acquisition task team. last year to source vaccine doses for the continent. But it appears the "The vaccines that most of the other countries have procured are vaccines that may not be ideal for South Africa from various perspectives," he has said.

European Union (EU) members will pay just 1.78 euros ($2.16) for AstraZeneca's shots, according to information leaked by a Belgian minister on Twitter last month.

Bilateral deals between wealthier governments and coronavirus vaccine manufacturers have raised concern over price hikes and lack of supply for low- and middle-income countries.

The World Health Organization last year warned against "vaccine nationalism" and "price gouging" once a successful shot was found.

AstraZeneca France told AFP in November that its shots would be capped at 2.5 euros (around $3) per dose "to provide vaccines to the widest population, with as fair access as possible".

The pharmaceutical giant did not immediately respond to requests for comment on the health ministry's price quote.

Answers to your 24 most pressing questions about the coronavirus vaccine, from side effects and costs to when you'll be able to get one

  Answers to your 24 most pressing questions about the coronavirus vaccine, from side effects and costs to when you'll be able to get one Coronavirus vaccines are the main chance the US has to dig itself out of the pandemic, and 10.6 million people have gotten their first shots so far. People are desperate to get vaccinated so they can protect themselves, see loved ones, and return to normal. The rollout so far has been slow and messier than planned, but US health officials say they're hitting the gas pedal in the weeks ahead. Here's what you need to know about the vaccine, from timeline to cost and side effects. Have a burning question you don't see here? Email reporter Kimberly Leonard at KLeonard@insider.com.

Similarities between the South Africa variant and another variant identified in Brazil suggest the Brazilian variant will show similar resistance The COVID-19 vaccine from Pfizer Inc and BioNTech SE is likely to protect against the more infectious variant of the virus discovered in Britain and now

Hungary has become the first country in the European Union to give preliminary approval to the Russian coronavirus vaccine , Sputnik V . On Thursday, Prime Minister Viktor Orban' s chief of staff confirmed both the Russian jab and the Oxford-AstraZeneca vaccine had been given the green light

South Africa's AstraZeneca vaccine order is part of 20 million secured doses to be delivered in the first half of 2021.

The WHO-backed Covax facility is expected to provide shots for 10 percent of the population between April and June.

Other vaccines will be provided via the African Union and bilateral contracts with suppliers that have not yet been disclosed.

Opposition groups have meanwhile criticised South Africa's inoculation strategy.

"Reports today indicate that... government will have to spend double what some other countries are paying for their vaccines," the main opposition Democratic Alliance party said Thursday, blaming poor planning and delayed negotiations.

Trade union Solidarity and prominent rights group Afriforum jointly announced plans to launch a legal battle against the government over lack of transparency.

"The government's non-disclosure of information is further proof why it cannot be trusted with a monopoly regarding the purchasing and distribution of Covid-19 vaccines," Afriforum said in a statement on Thursday.

South Africa is battling with a second wave of infections fuelled by a new coronavirus variant deemed more infectious by scientists.

To date the country has recorded over 1.3 million cases and 38,800 deaths.

The government aims to vaccinate two thirds of its population -- around 40 million out of nearly 60 million people -- to achieve herd immunity by the end of 2021.

cld-mgu/sch/ach

The Differences Between Covid Vaccines by Johnson & Johnson, Moderna, Pfizer, Astrazeneca .
Johnson & Johnson say their vaccine is 66 percent effective overall in preventing moderate to severe COVID-19.The Johnson & Johnson vaccine only requires one shot, which the company has said it will provide on a "non-profit" basis for the duration of the pandemic—costing around $10 a dose.

usr: 0
This is interesting!